US Stock MarketDetailed Quotes

CMMB Chemomab Therapeutics

Watchlist
  • 0.780
  • +0.010+1.30%
Trading Mar 28 15:03 ET
11.08MMarket Cap-378P/E (TTM)

Chemomab Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
31.04%8.2M
70.09%9.05M
130.72%28.53M
72.01%8.64M
187.69%8.32M
127.17%6.25M
213.13%5.32M
107.08%12.37M
158.70%5.02M
136.00%2.89M
Selling and administrative expenses
-4.94%3.18M
-16.04%2.16M
91.55%11.56M
4.01%2.75M
106.13%2.89M
130.98%3.34M
375.09%2.58M
368.40%6.03M
283.87%2.64M
623.71%1.4M
-General and administrative expense
-4.94%3.18M
-16.04%2.16M
91.55%11.56M
4.01%2.75M
106.13%2.89M
130.98%3.34M
375.09%2.58M
368.40%6.03M
283.87%2.64M
623.71%1.4M
Research and development costs
72.27%5.02M
150.89%6.89M
168.03%16.98M
147.38%5.9M
264.69%5.42M
122.95%2.91M
137.25%2.75M
35.23%6.33M
90.03%2.38M
44.23%1.49M
Operating profit
-31.04%-8.2M
-70.09%-9.05M
-130.72%-28.53M
-72.01%-8.64M
-187.69%-8.32M
-127.17%-6.25M
-213.13%-5.32M
-107.08%-12.37M
-158.70%-5.02M
-136.00%-2.89M
Net non-operating interest income expense
153.96%259K
46.76%317K
418.02%353K
3,266.67%380K
407.79%237K
-2,723.53%-480K
4,420.00%216K
-628.57%-111K
-33.33%-12K
-7,800.00%-77K
Total other finance cost
-153.96%-259K
-46.76%-317K
-418.02%-353K
-3,266.67%-380K
-407.79%-237K
2,723.53%480K
-4,420.00%-216K
628.57%111K
33.33%12K
7,800.00%77K
Other net income (expense)
Income before tax
-17.85%-7.94M
-71.08%-8.73M
-125.84%-28.18M
-64.06%-8.26M
-172.24%-8.08M
-143.10%-6.73M
-199.53%-5.1M
-109.68%-12.48M
-158.12%-5.04M
-142.48%-2.97M
Income tax
106.25%34K
21K
-534K
10K
0
-544K
0
0
0
0
Net income
-28.76%-7.97M
-71.49%-8.75M
-121.56%-27.65M
-64.26%-8.27M
-172.24%-8.08M
-123.47%-6.19M
-199.53%-5.1M
-109.68%-12.48M
-158.12%-5.04M
-142.48%-2.97M
Net income continuous Operations
-28.76%-7.97M
-71.49%-8.75M
-121.56%-27.65M
-64.26%-8.27M
-172.24%-8.08M
-123.47%-6.19M
-199.53%-5.1M
-109.68%-12.48M
-158.12%-5.04M
-142.48%-2.97M
Minority interest income
Net income attributable to the parent company
-28.76%-7.97M
-71.49%-8.75M
-121.56%-27.65M
-64.26%-8.27M
-172.24%-8.08M
-123.47%-6.19M
-199.53%-5.1M
-109.68%-12.48M
-158.12%-5.04M
-142.48%-2.97M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-28.76%-7.97M
-71.49%-8.75M
-121.56%-27.65M
-64.26%-8.27M
-172.24%-8.08M
-123.47%-6.19M
-199.53%-5.1M
-109.68%-12.48M
-158.12%-5.04M
-142.48%-2.97M
Basic earnings per share
-33.33%-0.72
-81.82%-0.8
-101.67%-2.42
-63.64%-0.72
-169.23%-0.7
-107.69%-0.54
-100.00%-0.44
-121.87%-1.2
-148.14%-0.44
-133.72%-0.26
Diluted earnings per share
-33.33%-0.72
-81.82%-0.8
-101.67%-2.42
-63.64%-0.72
-169.23%-0.7
-107.69%-0.54
-100.00%-0.44
-121.87%-1.2
-148.14%-0.44
-133.72%-0.26
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 31.04%8.2M70.09%9.05M130.72%28.53M72.01%8.64M187.69%8.32M127.17%6.25M213.13%5.32M107.08%12.37M158.70%5.02M136.00%2.89M
Selling and administrative expenses -4.94%3.18M-16.04%2.16M91.55%11.56M4.01%2.75M106.13%2.89M130.98%3.34M375.09%2.58M368.40%6.03M283.87%2.64M623.71%1.4M
-General and administrative expense -4.94%3.18M-16.04%2.16M91.55%11.56M4.01%2.75M106.13%2.89M130.98%3.34M375.09%2.58M368.40%6.03M283.87%2.64M623.71%1.4M
Research and development costs 72.27%5.02M150.89%6.89M168.03%16.98M147.38%5.9M264.69%5.42M122.95%2.91M137.25%2.75M35.23%6.33M90.03%2.38M44.23%1.49M
Operating profit -31.04%-8.2M-70.09%-9.05M-130.72%-28.53M-72.01%-8.64M-187.69%-8.32M-127.17%-6.25M-213.13%-5.32M-107.08%-12.37M-158.70%-5.02M-136.00%-2.89M
Net non-operating interest income expense 153.96%259K46.76%317K418.02%353K3,266.67%380K407.79%237K-2,723.53%-480K4,420.00%216K-628.57%-111K-33.33%-12K-7,800.00%-77K
Total other finance cost -153.96%-259K-46.76%-317K-418.02%-353K-3,266.67%-380K-407.79%-237K2,723.53%480K-4,420.00%-216K628.57%111K33.33%12K7,800.00%77K
Other net income (expense)
Income before tax -17.85%-7.94M-71.08%-8.73M-125.84%-28.18M-64.06%-8.26M-172.24%-8.08M-143.10%-6.73M-199.53%-5.1M-109.68%-12.48M-158.12%-5.04M-142.48%-2.97M
Income tax 106.25%34K21K-534K10K0-544K0000
Net income -28.76%-7.97M-71.49%-8.75M-121.56%-27.65M-64.26%-8.27M-172.24%-8.08M-123.47%-6.19M-199.53%-5.1M-109.68%-12.48M-158.12%-5.04M-142.48%-2.97M
Net income continuous Operations -28.76%-7.97M-71.49%-8.75M-121.56%-27.65M-64.26%-8.27M-172.24%-8.08M-123.47%-6.19M-199.53%-5.1M-109.68%-12.48M-158.12%-5.04M-142.48%-2.97M
Minority interest income
Net income attributable to the parent company -28.76%-7.97M-71.49%-8.75M-121.56%-27.65M-64.26%-8.27M-172.24%-8.08M-123.47%-6.19M-199.53%-5.1M-109.68%-12.48M-158.12%-5.04M-142.48%-2.97M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -28.76%-7.97M-71.49%-8.75M-121.56%-27.65M-64.26%-8.27M-172.24%-8.08M-123.47%-6.19M-199.53%-5.1M-109.68%-12.48M-158.12%-5.04M-142.48%-2.97M
Basic earnings per share -33.33%-0.72-81.82%-0.8-101.67%-2.42-63.64%-0.72-169.23%-0.7-107.69%-0.54-100.00%-0.44-121.87%-1.2-148.14%-0.44-133.72%-0.26
Diluted earnings per share -33.33%-0.72-81.82%-0.8-101.67%-2.42-63.64%-0.72-169.23%-0.7-107.69%-0.54-100.00%-0.44-121.87%-1.2-148.14%-0.44-133.72%-0.26
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg